Ichthyosis (X‐linked)
Epidemiology
The worldwide
incidence is 1:4000 male births. It is an X-linked recessive disorder that is
transmitted by asymptomatic female carriers and almost exclusively affects boys
and men.
Pathophysiology
Recessive
X‐linked
ichthyosis is caused by mutations in the STS gene encoding steroid
sulphatase. Around 90% of patients, diminution or complete absence of steroid
sulfatase activity is caused by a deletion of the entire STS gene on chromosome Xp22.31. Steroid sulfatase
deficiency results in impaired hydrolysis of cholesterol sulfate and
dehydroepiandrosterone sulfate (DHEAS), with subsequent accumulation of
cholesterol 3-sulfate in the epidermis. STS normally is concentrated in
lamellar bodies and secreted into the spaces between stratum corneum cells. It
degrades cholesterol sulfate, generating cholesterol for the epidermal barrier.
Cholesterol sulfate is a product of the odland bodies
that is discharged with them from the granular cells in to the intercellular
space and provides cell cohesion in the lower stratum corneum. As a result of
enzyme deficiency, cholesterol sulphate cannot be degraded and so it
accumulates in the epidermis which results in persistent cell cohesion even in
the upper stratum corneum. Beyond that, high
concentrations of cholesterol sulphate inhibit proteases such as kallikrein 5
and kallikrein 7 that are pivotal for normal degradation of corneodesmosomes. This
in turn leads to decreased desquamation, and as consequence corneocyte retention. RXLI can thus be considered as a prototypic example of a
retention hyperkeratosis. Increase of transepidermal water loss is even more
pronounced than in IV patients.
In women
pregnant with an affected fetus, steroid sulfatase deficiency in the fetal placenta
causes low or absent levels of estrogen in the urine and amniotic fluid because
of inadequate deconjugation of DHEAS (which is necessary for estrogen
synthesis). As a result, labor often fails to initiate spontaneously or
progress, due to insufficient dilation of the cervix. This can only be
partially overcome by oxytocin administration, often necessitating cesarean
section or forceps delivery.
XLI
occurs as a result of steroid sulfatase (SSase) deficiency, leading to an
accumulation of cholesterol sulfate (CSO4) in the outer epidermis,
erythrocyte cell membranes, and lipoprotein fractions of plasma. Whereas CSO4 levels
normally comprise ~1% of lipid mass in the stratum corneum, in XLI, CSO4 contents
can reach ~10–12%. Although the hydrolysis of CSO4 generates
some of the cholesterol required for the barrier, CSO4 is also
a potent inhibitor of HMG CoA reductase, a key enzyme involved in cholesterol
synthesis, thus further reducing cholesterol levels in XLI. The accumulation of
CSO4 coupled with cholesterol deficiency disrupts lamellar
membrane architecture, accounting for the barrier abnormality in XLI.
Clinical features
Onset is before
3 months of life. In ~90% of affected boys, steroid
sulfatase deficiency presents during the neonatal period with mild erythroderma and generalized peeling, often with exfoliation of large,
translucent scales. The typical large thick dark-brown, polygonal, adherent scales develop later during infancy or childhood
and are distributed symmetrically on the extremities, trunk, and neck. The
scales may encroach on the antecubital and popliteal fossae unlike IV. The
palms, soles and central face are characteristically spared, with the exception
of the preauricular area; some clinicians consider the latter to be a
pathognomonic feature. In around 30% of patients, the color of the scale is
light grey and these patients are often misdiagnosed as having IV. Dark
hyperkeratosis giving the lateral aspects of the trunk and the back of the neck
a ‘dirty look’ is a further feature which is typical of RXLI, and is usually
not present in IV. Fine scaling of the scalp is
frequently seen during early childhood but diminishes over time. In the
summertime, often spontaneous marked improvement can be observed, while in
winter the skin condition becomes worse, but (in contrast to ichthyosis
vulgaris) does not significantly subside with age.
Distribution of X-linked ichthyosis: trunk,
buttocks, and arms
Comma
shaped corneal opacity is a frequent finding in 10–50% of male patientsand in some female
carriers, if they undergo an expert slit-lamp
examination, but it usually does not affect vision. Male patients have a
20-fold increased incidence of cryptorchidism and, independent of testicular
maldescent, are thought to be at higher risk for developing testicular cancer
and hypogonadism. A higher prevalence of attention
deficit hyperactivity disorder has also been reported. Although steroid
sulfatase activity is measurably reduced in 85% of female carriers, the
remaining activity seems sufficient to prevent any skin manifestations.
Investigations
Pathology
Histology shows orthohyperkeratosis
and a thickened stratum granulosum. Ultrastructurally, a marked increase of
persistent corneodesmosomes typical for retention hyperkeratosis can be seen.
Other
diagnostic tests
Fluorescent in situ hybridization
analysis (FISH) for the STS gene shows deletion of the gene found in 90% of
patients which, when known in a female carrier, may also be utilized for
prenatal diagnosis (via chorionic villi or amniotic fluid samples). However,
non-invasive prenatal diagnosis is the presence of non-hydrolyzed sulfated
steroid hormone in maternal urine is preferred. Cholesterol sulfate levels are
elevated in the serum, epidermis and scales. Accumulation
of (hydroxy) cholesterol sulfate can be detected indirectly by increased
migration of the β-fraction in serum
lipoprotein electrophoresis, or measured directly by liquid chromatography-mass
spectrometry (LC-MS) of serum, epidermal scale, placental tissue, or amniotic
fluid. In addition, it is possible to measure steroid sulphatase enzymatic
activity biochemically in leukocytes, fibroblasts, keratinocytes, or placental
tissue.
Differential Diagnosis
Clinically, ichthyosis vulgaris
is distinguished by its sparing of the neck and other flexural areas as well as
the presence of hyperlinear palms and keratosis pilaris.
Treatment
Recessive X‐linked ichthyosis patients benefit
from the same therapeutic strategy that is applied for icthyosis vulgaris,
namely the use of moisturizers. Again, excellent results can be achieved with a
glycerol containing cream. Systemic retinoids are rarely necessary.